Exploring how CBD affects THC's psychoactive effects

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate the modulation of THC's psychoactive effects by CBD at various ratios and doses. Participants will inhale different combinations of CBD and THC to assess their behavioral and pharmacological responses. The research seeks to fill gaps in understanding how CBD influences THC effects, which is crucial for public safety and informed cannabis use. By evaluating these interactions, the study hopes to provide insights that can guide regulatory bodies and improve cannabis consumption guidelines.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Between 21 and 49 years of age, inclusively;
2. Have used cannabis at least once in their lifetime and have used cannabis three days or less in the 30 days prior to enrollment;
3. Be able to provide a signed informed consent;
4. Willing to comply with study procedures and requirements as per protocol;
5. Have a forced expiratory volume in first second (FEV) less than or equal to 90 %;
6. Able to communicate and understand English or French language;
7. For female participants:

   a. No childbearing potential, defined as: i. postmenopausal (12 months of spontaneous amenorrhea and ≥ 45 years of age); or ii. Documented surgically sterilized (i.e., tubal ligation, hysterectomy, or bilateral oophorectomy); or b. For female of childbearing potential: i. Must have negative pregnancy test result at screening and at subsequent visits.

ii. AND have no pregnancy plan while on the study iii. AND must agree to use a medically accepted method of birth control throughout the study.

Exclusion criteria

Participants will be excluded if any of the following criteria are met:

1. Any disabling medical condition, as assessed by medical history, physical exam, vital signs and/or laboratory assessments that, in the opinion of the study physician, precludes safe participation in the study or the ability to provide fully informed consent;
2. Severe psychiatric condition (history of schizophrenia, schizoaffective disorder or bipolar disorder; current acute psychosis, mania or current suicidality based on the Mini International Neuropsychiatric Interview);
3. Any other disabling, unstable or acute mental condition that, in the opinion of the study physician, precludes safe participation in the study or ability to provide fully informed consent;
4. Known chronic liver disease or aspartate transaminase/alanine transaminase (AST/ALT) two times higher than upper limit of normal values at screening visit;
5. Blood pressure higher than 130/80 mmHg;
6. Kidney disorders;
7. Bleeding disorders;
8. Current moderate or severe DSM-5 substance use disorder (except nicotine) according to SCID-V;
9. Currently pregnant, breastfeeding or planning to become pregnant either at screening or while enrolled in the study;
10. Pending legal action or other reason that, in the opinion of the study physician, might prevent study completion;
11. Use of medication within 7 days of experimental sessions; which, in the opinion of the Investigator, may interact with cannabis.
12. Participation in clinical studies or undergoing other investigational procedure involving cannabis or cannabinoids administration within 30 days prior to randomization.
13. Resting heart rate over 100 beats per minute.
14. Current body mass index (BMI) over 29.9 kg/m2.
15. Any clinically significant electrocardiogram abnormalities at screening visit.

Where it's running

• Centre de recherche du Centre Hospitalier Universitaire de Montréal
  Montreal, Quebec, Canada Recruiting

Study contacts

• Principal investigator: Didier Jutras-Aswad, MD, MS — Crchum
• Study coordinator: Pamela Lachance, PhD
• Email: pamela.lachance-touchette.chum@ssss.gouv.qc.ca
• Phone: 514-890-8000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How marijuana (THC) and tobacco interact when used together

  This test tries to see if combining marijuana (THC) and tobacco changes blood drug levels and how people feel and respond physically in adults who regularly use both.

  Recruiting Phase 2 University of California, San Francisco · San Francisco, California · NCT05999383

• Effects of cannabis on the microbiome and inflammation in HIV

  This study is testing how cannabis compounds THC and CBD affect gut health and inflammation in people living with HIV.

  Recruiting Phase 2 University of California, San Diego · San Diego, California · NCT05514899

• Cannabis Effects on Recognition Memory and Brain Waves in Regular Users

  This study tests how THC- and CBD-containing cannabis strains affect recognition memory and brain activity in regular cannabis users.

  Recruiting University of Colorado, Boulder · Boulder, Colorado · NCT07679581

• Hemp-based CBD topical lotion pharmacokinetics in healthy adults

  This study tests how a high‑CBD, low‑THC hemp lotion behaves in the body after short‑ and longer‑term use in healthy adults.

  Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT07603518

• Repeated CBD to change how cannabis affects mood and pain

  This study will test whether taking CBD repeatedly changes the behavioral effects and pain relief experienced by adult cannabis users.

  Recruiting Early Phase 1 University of Kentucky · Lexington, Kentucky · NCT07434895

• How menstrual-cycle hormones change women's responses to cannabis

  This study will see if occasional biological female cannabis users respond differently to a measured THC dose at three phases of their menstrual cycle compared with a placebo.

  Recruiting Maastricht University · Maastricht · NCT07417059

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.